All In Biotech

Free tool

FAERS Monitor: Symtuza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210455 or its brand name (Symtuza, Cobicistat, Darunavir, Emtricitabine, Tenofovir Alafenamide Fumarate). Reports on generic versions are filed under their own applications.

Reports

2,754

Serious

2,063

75% of reports

Hospitalization

310

Death reported

110

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • bone density decreased1,067
  • bone loss609
  • osteonecrosis608
  • chronic kidney disease578
  • tooth loss565
  • multiple fractures529
  • renal failure509
  • osteoporosis433
  • renal injury426
  • skeletal injury373
  • pain368
  • emotional distress353
  • anxiety334
  • anhedonia317
  • osteopenia247

Reports by year received

View as table
YearReports
20151
201831
2019302
2020942
2021418
2022337
2023271
2024224
2025156
202672

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,405 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bone lossSignal609322.4300.0187,055
skeletal injurySignal373285.7259.5101,791
bone density decreasedSignal1,067269.2256.5275,554
multiple fracturesSignal529254.1235.0128,917
tooth lossSignal565213.9198.5116,380
osteonecrosisSignal608144.0134.184,745
osteopeniaSignal247126.4112.130,116
renal injurySignal426111.1101.745,761
anhedoniaSignal31793.284.028,520
osteoporosisSignal43381.274.533,944
chronic kidney diseaseSignal57858.554.432,499
renal failureSignal50929.427.213,961
emotional distressSignal35322.320.37,192
anxietySignal3349.08.12,388
painSignal3684.64.21,056

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.